Physician profile
Joy Sickles
NPI 1942649975
$1,480.08
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,401 · 2022: $79.30.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $250.57 | 2021 | |
| Abbvie INC. | $187.66 | 2021-2022 | |
| Lilly USA, LLC | $155.49 | 2021 | |
| Merck Sharp & Dohme LLC | $133.82 | 2021-2022 | |
| Novo Nordisk INC | $124.05 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $122.79 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $116.60 | 2021-2022 | |
| Glaxosmithkline, LLC. | $87.74 | 2021 | |
| Nestle Healthcare Nutrition INC. | $36.32 | 2021 | |
| Grifols USA, LLC | $31.69 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.79 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.67 | 2021 | |
| Janssen Pharmaceuticals, INC | $29.63 | 2021 | |
| Medtronic, INC. | $28.35 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.27 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.86 | 2021 | |
| Amgen INC. | $16.57 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.05 | 2021 | |
| Esperion Therapeutics, INC. | $15.84 | 2021 | |
| Mylan Specialty L.P. | $15.54 | 2021 | |
| Supernus Pharmaceuticals, INC. | $11.78 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Sickles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.